Purinergic Receptors

Ticagrelor View larger

Ticagrelor

AT0179

CAS 274693-27-5

More details

Molarity Calculation Cart®

HOW TO ORDER

$34.00

$34.00 per 10 mg

Data sheet

Molecular FormulaC23H28F2N6O4S
Molecular Weight522.57
CAS Numbers274693-27-5
Storage Condition0C Short Term, -20C Long Term
SolubilityDMSO
Purity98% by HPLC
SMILES CodeCCCSc1nc(N[C@@H]2C[C@H]2c2ccc(F)c(F)c2)c2nnn([C@@H]3C[C@H](OCCO)[C@@H](O)[C@H]3O)c2n1
ReferencesVAN Giezen JJ, et al. J Thromb Haemost, 2009, 7[9], 1556-1565.

More info

Ticagrelor (AR-C 126532XX), produced by AstraZeneca, is an inhibitor of platelet aggregation. Unlike clopidogrel, ticagrelor is not a prodrug required metabolic activation. The drug was approved for use in the European Union by the European Commission on December 3, 2010, and by the US FDA on July 20, 2011. Its trade names are Brilinta (US), Brilique(EU) and Possia(EU).